A detailed history of Clg LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Clg LLC holds 3,123 shares of ABT stock, worth $406,083. This represents 0.11% of its overall portfolio holdings.

Number of Shares
3,123
Previous 3,094 0.94%
Holding current value
$406,083
Previous $421 Million 0.59%
% of portfolio
0.11%
Previous 0.13%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$120.51 - $136.62 $3,494 - $3,961
29 Added 0.94%
3,123 $418 Million
Q2 2025

Aug 14, 2025

BUY
$123.95 - $138.08 $619 - $690
5 Added 0.16%
3,094 $421 Million
Q1 2025

Apr 21, 2025

BUY
$111.1 - $140.22 $666 - $841
6 Added 0.19%
3,089 $410 Million
Q4 2024

Apr 11, 2025

BUY
$111.93 - $119.39 $345,080 - $368,079
3,083 New
3,083 $349 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Clg LLC Portfolio

Follow Clg LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clg LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clg LLC with notifications on news.